Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors

Neuroendocrinology

Volumn 80, Issue SUPPL. 1, 2004, Pages 74-78

  Ruszniewski, Philippe ^a   O'Toole, Dermot ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Ablative therapies; Chemoembolization; Gastroenteropancreatic endocrine tumors; Liver metastases; Radiofrequency ablation

Indexed keywords

ANTINEOPLASTIC AGENT; SOMATOSTATIN DERIVATIVE;

ABDOMINAL PAIN; ARTIFICIAL EMBOLISM; BLEEDING; CARCINOID SYNDROME; CATHETER ABLATION; CHEMOEMBOLIZATION; CONFERENCE PAPER; CORRELATION ANALYSIS; FEVER; HEPATIC ARTERY LIGATION; HUMAN; INTESTINE TUMOR; KIDNEY FAILURE; LIVER METASTASIS; NAUSEA; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGY; SIDE EFFECT; STOMACH CANCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; ULCER; VASCULAR PATENCY; VOMITING;

CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CRYOTHERAPY; HUMANS; LIVER NEOPLASMS; NEUROENDOCRINE TUMORS; VASECTOMY;

EID: 6044233448     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080746     Document Type: Conference Paper

References (42)

1. Jensen R: Natural history of digestive endocrine tumors; in Mignon MCJ, Colombe JF (eds): Recent Advances in the Pathophysiology and Management of Inflammatory Bowel Disease and Digestive Endocrine Tumors. Paris, John Libbey Eurotext, 1999, pp 192-219.
2. Godwin JD 2nd: Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975;36:560-569.
3. Zeitels J, Naunheim K, Kaplan EL, Straus F 2nd: Carcinoid tumors: A 37-year experience. Arch Surg 1982;117:732-737.
4. McDermott EW, Guduric B, Brennan MF: Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg 1994;81:1007-1009.
5. Madeira I, Terris B, Voss M, Denys A, Sauvanet A, Flejou JF, Vilgrain V, Belghiti J, Bernades P, Ruszniewski P: Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 1998;43:422-427.
6. O'Toole D, Kianmanesh R, Farges O, Ruszniewski P: Treatment of pancreatic-duodenal endocrine tumors. Rev Prat 2002;52:1546-1553.
7. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS: Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990;108:1091-1096.
8. Broder LE, Carter SK: Pancreatic islet cell carcinoma. 2. Results of therapy with streptozotocin in 52 patients. Ann Intern Med 1973;79:108-118.
9. Moertel CG, Johnson CM, McKusick MA, Martin JK Jr, Nagorney DM, Kvols LK, Rubin J, Kunselman S: The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994;120:302-309.
10. Kessinger A, Foley JF, Lemon HM: Therapy of malignant APUD cell tumors. Effectiveness of DTIC. Cancer 1983;51:790-794.
11. Engstrom PF, Lavin PT, Moertel CG, Folsch E, Douglass HO Jr: Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol 1984;2:1255-1259.
12. Roche A: Chemio-embolization hépatique. Bull Cancer 1989;76:1029-1037.
13. Taourel P, Dauzat M, Lafortune M, Pradel J, Rossi M, Bruel JM: Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinomas. Radiology 1994;191:189-192.
14. de Baere T, Dufaux J, Roche A, Counnord JL, Berthault MF, Denys A, Pappas P: Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: Experimental study. Radiology 1995;194:165-170.
15. Bengmark S, Fredlund P, Hafstrom LO, Vang J: Present experiences with hepatic dearterialization in liver neoplasm. Prog Surg 1974;13:141-166.
16. Sivula A, Sipponen P: The effect of hepatic dearterialization and re-dearterialization on carcinoid liver metastases. Ann Chir Gynaecol 1976;65:168-175.
17. Jugdutt BI, Watanabe M, Turner FW: Hepatic artery ligation in treatment of carcinoid syndrome. Can Med Assoc J 1975;112:325-327.
18. Arcenas AG AJ, Carrasco CH, Levin B, Wallace S: Vascular occlusive therapy of pancreatic endocrine tumors metastatic to the liver; in Jensen MMR (ed): Endocrine Tumors of the Pancreas (Front Gastrointest Research). Basel, Karger, 1995, vol 23, pp 439-450.
19. Bengmark S, Ericsson M, Lunderquist A, Martensson H, Nobin A, Sako M: Temporary liver dearterialization in patients with metastatic carcinoid disease. World J Surg 1982;6:46-53.
20. Allison DJ, Modlin IM, Jenkins WJ: Treatment of carcinoid liver metastases by hepatic-artery embolisation. Lancet 1977;ii:1323-1325.
21. Ajani JA, Carrasco CH, Charnsangavej C, Samaan NA, Levin B, Wallace S: Islet cell tumors metastatic to the liver: Effective palliation by sequential hepatic artery embolization. Ann Intern Med 1988;108:340-344.
22. Marlink RG, Lokich JJ, Robins JR, Clouse ME: Hepatic arterial embolization for metastatic hormone-secreting tumors. Technique, effectiveness, and complications. Cancer 1990;65:2227-2232.
23. Therasse E, Breittmayer F, Roche A, De Baere T, Indushekar S, Ducreux M, Lasser P, Elias D, Rougier P: Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 1993;189:541-547.
24. Roche A, Girish BV, de Baere T, Baudin E, Boige V, Elias D, Lasser P, Schlumberger M, Ducreux M: Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003;13:136-140.
25. Nesovic M, Ciric J, Radojkovic S, Zarkovic M, Durovic M: Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization. J Endocrinol Invest 1992;15:543-547.
26. Dominguez S, Denys A, Madeira I, Hammel P, Vilgrain V, Menu Y, Bernades P, Ruszniewski P: Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol 2000;12:151-157.
27. Casadei R, Tomassetti P, Rossi C, la Donna M, Migliori M, Marrano D: Treatment of metastatic glucagonoma to the liver: Case report and literature review. Ital J Gastroenterol Hepatol 1999;31:308-312.
28. Lee SM, Forbes A, Williams R: Metastatic islet cell tumour with clinical manifestations of insulin and glucagon excess: Successful treatment by hepatic artery embolization and chemotherapy. Eur J Surg Oncol 1988;14:265-268.
29. Ruszniewski P, Rougier P, Roche A, Legmann P, Sibert A, Hochlaf S, Ychou M, Mignon M: Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 1993;71:2624-2630.
30. Diaco DS, Hajarizadeh H, Mueller CR, Fletcher WS, Pommier RF, Woltering EA: Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization. Am J Surg 1995;169:523-528.
31. Clouse ME, Perry L, Stuart K, Stokes KR: Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion 1994;55(suppl 3):92-97.
32. Ruszniewski P, Malka D: Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 2000;62(suppl 1):79-83.
33. Mavligit GM, Pollock RE, Evans HL, Wallace S: Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer 1993;72:375-380.
34. Liu LX, Zhang WH, Jiang HC: Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 2003;9:193-200.
35. Hellman P, Ladjevardi S, Skogseid B, Akerstrom G, Elvin A: Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 2002;26:1052-1056.
36. Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A: Cryoablation of unresectable malignant liver tumors. Am J Surg 1996;171:27-31.
37. Cozzi PJ, Englund R, Morris DL: Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors. Cancer 1995;76:501-509.
38. Sheen AJ, Poston GJ, Sherlock DJ: Cryotherapeutic ablation of liver tumours. Br J Surg 2002;89:1396-1401.
39. Duperier T, Ali A, Pereira S, Davies RJ, Ballantyne GH: Laparoscopic cryoablation of a metastatic carcinoid tumor. J Laparoendosc Adv Surg Tech A 2001;11:105-109.
40. Shapiro RS, Shafir M, Sung M, Warner R, Glajchen N: Cryotherapy of metastatic carcinoid tumors. Abdom Imaging 1998;23:314-317.
41. Seifert JK, Cozzi PJ, Morris DL: Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol 1998;14:175-183.
42. Tait IS, Yong SM, Cuschieri SA: Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br J Surg 2002;89:1613-1619.